The problem [1] with the European pharmaceuticals industry--at least in part--is biotechnology. Or that's what the European Federation of Pharmaceutical Industries and Associations believes. The big trade association says that the slowdown in new drug approvals [2] seen around the world can be directly linked to the biotech revolution. Report [3]